Kewaunee Scientific Corporation (KEQU)

Every figure this model derived for KEQU, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-04-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 3,937,000 PaymentsToAcquireProductiveAssets 2026-04-30
cash 9,950,000 CashAndCashEquivalentsAtCarryingValue 2026-04-30
current assets 105,397,000 AssetsCurrent 2026-04-30
current liabilities 48,351,000 LiabilitiesCurrent 2026-04-30
equity 74,718,000 StockholdersEquity 2026-04-30
interest expense 3,862,000 InterestExpenseNonoperating 2026-04-30
ocf 18,633,000 NetCashProvidedByUsedInOperatingActivities 2026-04-30
revenue 281,999,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-04-30
sbc 2,126,000 ShareBasedCompensation 2026-04-30

The ratios

The figures themselves rather than their scores — what somebody looking up KEQU on one particular measure came for.

RatioValue
cash operating margin8.91
current ratio2.38
current ratio reported2.18
deferred revenue growth-31.63
dilution pct0.13
ebit yoy-5.88
fcf margin5.21
growth cv0.83
interest cover4.33
net debt ebitda0.67
operating margin5.93
owner earnings margin4.46
revenue growth17.27
revenue growth per share17.11
roic14.64
rule of 4023.2
sbc pct revenue0.75

What to be careful about

What this model itself distrusts about KEQU's figures. Written by the derivation as it ran, not added afterwards.